High-level quadriplegia is a devastating condition with limited treatment options. Bone marrow derived stem cells (BMSCs) are reported to have immunomodulatory and neurotrophic effects in spinal cord injury (SCI). We report a subject with complete C2 SCI who received three anatomically targeted intrathecal infusions of BMSCs under a single-patient expanded access investigational new drug (IND). She underwent intensive physical therapy and was followed for >2 years. At end-point, her American Spinal Injury Association Impairment Scale (AIS) grade improved from A to B, and she recovered focal pressure touch sensation over several body areas. We conducted serial neurophysiological testing to monitor changes in residual connectivity. Motor, sensory, and autonomic system testing included motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electromyography (EMG) recordings, F waves, galvanic skin responses, and tilt-table responses. The quality and magnitude of voluntary EMG activations increased over time, but remained below the threshold of clinically obvious movement. Unexpectedly, at 14 months post-injury, deep inspiratory maneuvers triggered respiratory-like EMG bursting in the biceps and several other muscles. This finding means that connections between respiratory neurons and motor neurons were newly established, or unmasked. We also report serial analysis of MRI, International Standards for Neurological Classification of SCI (ISNCSCI), pulmonary function, pain scores, cerebrospinal fluid (CSF) cytokines, and bladder assessment. As a single case, the linkage of the clinical and neurophysiological changes to either natural history or to the BMSC infusions cannot be resolved. Nevertheless, such detailed neurophysiological assessment of high cervical SCI patients is rarely performed. Our findings indicate that electrophysiology studies are sensitive to define both residual connectivity and new plasticity.
Get full access to this article
View all access options for this article.
References
1.
CarterR.E. (1979). Experiences with high tetraplegics. Paraplegia, 17, 140–146.
2.
ShaoJ., ZhuW., ChenX., JiaL., SongD., ZhouX., YanW., and ZhangY. (2011). Factors associated with early mortality after cervical spinal cord injury. J. Spinal Cord Med., 34, 555–562.
3.
AhoniemiE., PohjolainenT., and KautiainenH. (2011). Survival after spinal cord injury in Finland. J. Rehabil. Med., 43, 481–485.
4.
HarropJ.S., HashimotoR., NorvellD., RaichA., AarabiB., GrossmanR.G., GuestJ.D., TatorC.H., ChapmanJ., and FehlingsM.G. (2012). Evaluation of clinical experience using cell-based therapies in patients with spinal cord injury: a systematic review. J. Neurosurg. Spine, 17, 230–246.
5.
AssinckP., DuncanG.J., HiltonB.J., PlemelJ.R., and TetzlaffW. (2017). Cell transplantation therapy for spinal cord injury. Nat. Neurosci., 20, 637–647.
6.
ManleyN.C., PriestC.A., DenhamJ., WirthE.D., 3rd, and LebkowskiJ.S. (2017). Human embryonic stem cell-derived oligodendrocyte progenitor cells: preclinical efficacy and safety in cervical spinal cord injury. Stem Cells Transl. Med., 6, 1917–1929.
7.
AndersonK.D., GuestJ.D., DietrichW.D., BungeM.B., CurielR., DididzeM., GreenB.A., KhanA., PearseD.D., Saraf-LaviE., Widerstrom-NogaE., WoodP., and LeviA.D. (2017). Safety of autologous human Schwann cell transplantation in subacute thoracic spinal cord injury. J. Neurotrauma, 34, 2950–2963.
8.
LeviA.D., OkonkwoD.O., ParkP., JenkinsA.L.3rd, KurpadS.N., ParrA.M., GanjuA., AarabiB., KimD., CashaS., FehlingsM.G., HarropJ.S., AndersonK.D., GageA., HsiehJ., HuhnS., CurtA., and GuzmanR. (2017). Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery, 82, 562–575.
9.
CurtisE., GabelB.C., MarsalaM. and CiacciJ.D. (2016). 172 A Phase I, open-label, single-site, safety study of human spinal cord-derived neural stem cell transplantation for the treatment of chronic spinal cord injury. Cell Stem Cell, 22, 941–950e946.
10.
MitchellR.A., and BergerA.J. (1975). Neural regulation of respiration. Am Rev Respir Dis, 111, 206–224.
11.
WarrenP.M., and AlilainW.J. (2014). The challenges of respiratory motor system recovery following cervical spinal cord injury. Prog. Brain Res., 212, 173–220.
12.
BrinzeuA., and SindouM. (2017). Functional anatomy of the accessory nerve studied through intraoperative electrophysiological mapping. J. Neurosurg., 126, 913–921.
13.
KrassioukovA. (2009). Autonomic function following cervical spinal cord injury. Respir. Physiol. Neurobiol., 169, 157–164.
14.
HuY., LiaoL.M., JuY.H., FuG., ZhangH.Y., and WuH.X. (2012). Intravenously transplanted bone marrow stromal cells promote recovery of lower urinary tract function in rats with complete spinal cord injury. Spinal Cord, 50, 202–207.
15.
LimJ.Y., JeongC.H., JunJ.A., KimS.M., RyuC.H., HouY., OhW., ChangJ.W., and JeunS.S. (2011). Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res. Ther., 2, 38.
16.
MotheA.J., BozkurtG., CatapanoJ., ZabojovaJ., WangX., KeatingA., and TatorC.H. (2011). Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord, 49, 967–973.
17.
ZuritaM., AguayoC., BonillaC., RodriguezA., and VaqueroJ. (2013). Perilesional intrathecal administration of autologous bone marrow stromal cells achieves functional improvement in pigs with chronic paraplegia. Cytotherapy, 15, 1218–1227.
18.
KakabadzeZ., KipshidzeN., MardaleishviliK., ChutkerashviliG., ChelishviliI., HardersA., LoladzeG., ShatirishviliG., KipshidzeN., ChakhunashviliD., and ChutkerashviliK. (2016). Phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury. Stem Cells Int. 2016, 6768274.
19.
KaramouzianS., Nematollahi-MahaniS.N., NakhaeeN., and EskandaryH. (2012). Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin. Neurol. Neurosurg., 114, 935–939.
20.
CristanteA.F., Barros-FilhoT.E., TatsuiN., MendroneA., CaldasJ.G., CamargoA., AlexandreA., TeixeiraW.G., OliveiraR.P., and MarconR.M. (2009). Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord, 47, 733–738.
21.
Ben-DavidU., and BenvenistyN. (2011). The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer, 11, 268–277.
22.
LoB., and ParhamL. (2009). Ethical issues in stem cell research. Endocr. Rev., 30, 204–213.
23.
PittengerM.F., MackayA.M., BeckS.C., JaiswalR.K., DouglasR., MoscaJ.D., MoormanM.A., SimonettiD.W., CraigS., and MarshakD.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.
24.
RamakrishnanA., Torok-StorbB., and PillaiM.M. (2013). Primary marrow-derived stromal cells: isolation and manipulation. Methods Mol. Biol., 1035, 75–101.
25.
IdeC., NakanoN., and KanekiyoK. (2016). Cell transplantation for the treatment of spinal cord injury – bone marrow stromal cells and choroid plexus epithelial cells. Neural Regen. Res., 11, 1385–1388.
26.
NakanoN., NakaiY., SeoT.B., YamadaY., OhnoT., YamanakaA., NagaiY., FukushimaM., SuzukiY., NakataniT., and IdeC. (2010). Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci. Lett., 483, 57–61.
27.
MeadB., and TomarevS. (2017). Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells Transl. Med., 6, 1273–1285.
28.
KorethJ., SchlenkR., KopeckyK.J., HondaS., SierraJ., DjulbegovicB.J., WadleighM., DeAngeloD.J., StoneR.M., SakamakiH., AppelbaumF.R., DohnerH., AntinJ.H., SoifferR.J., and CutlerC. (2009). Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA, 301, 2349–2361.
29.
Di NicolaM., Carlo-StellaC., MagniM., MilanesiM., LongoniP.D., MatteucciP., GrisantiS., and GianniA.M. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838–3843.
30.
LysaghtT., KerridgeI.H., SippD., PorterG., and CappsB.J. (2017). Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations. J. Bioeth. Inq., 14, 261–273.
31.
LysaghtT., KerridgeI., SippD., PorterG., and CappsB.J. (2013). Oversight for clinical uses of autologous adult stem cells: lessons from international regulations. Cell Stem Cell, 13, 647–651.
LauD., OgboguU., TaylorB., StafinskiT., MenonD., and CaulfieldT. (2008). Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell, 3, 591–594.
34.
ThirabanjasakD., TantiwongseK., and ThornerP.S. (2010). Angiomyeloproliferative lesions following autologous stem cell therapy. J. Am. Soc. Nephrol., 21, 1218–1222.
35.
KuriyanA.E., AlbiniT.A., TownsendJ.H., RodriguezM., PandyaH.K., LeonardR.E.2nd, ParrottM.B., RosenfeldP.J., FlynnH.W.Jr., and GoldbergJ.L. (2017). Vision loss after intravitreal injection of autologous “stem cells”. for AMD. N. Engl. J. Med., 376, 1047–1053.
36.
AlderaziY.J., CoonsS.W., and ChapmanK. (2012). Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis. J. Child Neurol., 27, 632–635.
37.
MouiseddineM., FrancoisS., SemontA., SacheA., AllenetB., MathieuN., FrickJ., ThierryD., and ChapelA. (2007). Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br. J. Radiol., 80, Spec. No. 1, S49–55.
38.
HerreraM.B., BussolatiB., BrunoS., MorandoL., Mauriello-RomanazziG., SanavioF., StamenkovicI., BianconeL., and CamussiG. (2007). Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 72, 430–441.
39.
BakshiA., HunterC., SwangerS., LeporeA., and FischerI. (2004). Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J. Neurosurg. Spine, 1, 330–337.
40.
BakshiA., BarshingerA.L., SwangerS.A., MadhavaniV., ShumskyJ.S., NeuhuberB., and FischerI. (2006). Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J. Neurotrauma, 23, 55–65.
41.
OhtaM., SuzukiY., NodaT., EjiriY., DezawaM., KataokaK., ChouH., IshikawaN., MatsumotoN., IwashitaY., MizutaE., KunoS., and IdeC. (2004). Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol., 187, 266–278.
42.
NakanoN., NakaiY., SeoT.B., HommaT., YamadaY., OhtaM., SuzukiY., NakataniT., FukushimaM., HayashibeM. and IdeC. (2013). Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats. PLoS One, 8, e73494.
43.
SatakeK., LouJ., and LenkeL.G. (2004). Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) 29, 1971–1979.
44.
CizkovaD., NovotnaI., SlovinskaL., VanickyI., JergovaS., RosochaJ., and RadonakJ. (2011). Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J. Neurotrauma, 28, 1951–1961.
45.
Biering-SorensenF., CharlifueS., DeVivoM., NoonanV., PostM., StriplingT. and WingP. (2006). International spinal cord injury data sets. Spinal Cord, 44, 530–534.
46.
HareJ.M., FishmanJ.E., GerstenblithG., DiFede VelazquezD.L., ZambranoJ.P., SuncionV.Y., TracyM., GhersinE., JohnstonP.V., BrinkerJ.A., BretonE., Davis-SproulJ., SchulmanI.H., ByrnesJ., MendizabalA.M., LoweryM.H., RouyD., AltmanP., Wong Po FooC., RuizP., AmadorA., Da SilvaJ., McNieceI.K., HeldmanA.W., GeorgeR., and LardoA. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA, 308, 2369–2379.
47.
ZakrasekE.C., NielsonJ.L., KosarchukJ.J., CrewJ.D., FergusonA.R., and McKennaS.L. (2017). Pulmonary outcomes following specialized respiratory management for acute cervical spinal cord injury: a retrospective analysis. Spinal Cord, 55, 559–565.
48.
KimK.N., GuestJ.D., OhJ.S., PennantW.A., YoonD.H., and HaY. (2010). Effect of primate bone marrow stromal cells on survival and neurite outgrowth. Neuroreport, 21, 877–881.
49.
Da SilvaJ.S., and HareJ.M. (2013). Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods Mol. Biol., 1037, 145–163.
50.
FarhatH.I., ElhammadyM.S., LeviA.D., and Aziz-SultanM.A. (2011). Cervical subarachnoid catheter placement for continuous cerebrospinal fluid drainage: a safe and efficacious alternative to the classic lumbar cistern drain. Neurosurgery, 68, 52–56.
51.
FlackS.H., and BernardsC.M. (2010). Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. Anesthesiology, 112, 165–173.
52.
FurbyA., BourriezJ.L., JacquessonJ.M., Mounier-VehierF., and GuieuJ.D. (1992). Motor evoked potentials to magnetic stimulation: technical considerations and normative data from 50 subjects. J. Neurol., 239, 152–156.
53.
ShieldsC.B., Ping ZhangY., ShieldsL.B., BurkeD.A., and GlassmanS.D. (2006). Objective assessment of cervical spinal cord injury levels by transcranial magnetic motor-evoked potentials. Surg. Neurol., 66, 475–483.
54.
WilsonS.A., ThickbroomG.W., and MastagliaF.L. (1993). Transcranial magnetic stimulation mapping of the motor cortex in normal subjects. The representation of two intrinsic hand muscles. J. Neurol. Sci., 118, 134–144.
55.
SherwoodA.M., McKayW.B. and DimitrijevicM.R. (1996). Motor control after spinal cord injury: assessment using surface EMG. Muscle Nerve, 19, 966–979.
56.
LissensM.A., De MuynckM.C., DecleirA.M., and VanderstraetenG.G. (1995). Motor evoked potentials of the abdominal muscles elicited through magnetic transcranial brain stimulation. Muscle Nerve, 18, 1353–1354.
57.
JungM.C., KimS.J., RheeJ.J., and LeeD.H. (2016). Electromyographic activities of the subscapularis, supraspinatus and infraspinatus muscles during passive shoulder and active elbow exercises. Knee Surg. Sports Traumatol. Arthrosc., 24, 2238–2243.
58.
FerrarioV.F., SforzaC., SerraoG., FragnitoN., and GrassiG. (2001). The influence of different jaw positions on the endurance and electromyographic pattern of the biceps brachii muscle in young adults with different occlusal characteristics. J. Oral Rehabil., 28, 732–739.
59.
CalderK.M., HallL.A., LesterS.M., InglisJ.G., and GabrielD.A. (2005). Reliability of the biceps brachii M-wave. J. Neuroeng. Rehabil., 2, 33.
60.
DesmedtJ.E., and CheronG. (1980). Central somatosensory conduction in man: neural generators and interpeak latencies of the far-field components recorded from neck and right or left scalp and earlobes. Electroencephalogr. Clin. Neurophysiol., 50, 382–403.
61.
EmersonR.G., SeyalM., and PedleyT.A. (1984). Somatosensory evoked potentials following median nerve stimulation. I. The cervical components. Brain, 107, Pt. 1, 169–182.
62.
MacDonaldD.B., Al ZayedZ., and StigsbyB. (2005). Tibial somatosensory evoked potential intraoperative monitoring: recommendations based on signal to noise ratio analysis of popliteal fossa, optimized P37, standard P37, and P31 potentials. Clin. Neurophysiol., 116, 1858–1869.
63.
MacDonaldD.B., Al-ZayedZ., StigsbyB., and Al-HomoudI. (2009). Median somatosensory evoked potential intraoperative monitoring: recommendations based on signal-to-noise ratio analysis. Clin. Neurophysiol., 120, 315–328.
64.
HayJ.E., TaylorP.K., and NukadaH. (1997). Auditory and inspiratory gasp-evoked sympathetic skin response: age effects. J. Neurol. Sci., 148, 19–23.
65.
NagarajaraoH.S., KumarB.N., WattJ.W., WireduE., and BhamidimarriK. (2006). Bedside assessment of sympathetic skin response after spinal cord injury: a brief report comparing inspiratory gasp and visual stimulus. Spinal Cord, 44, 217–221.
66.
TanakaM., UchiyamaM., and KitanoM. (1979). Gastroduodenal disease in chronic spinal cord injuries. An endoscopic study. Arch. Surg., 114, 185–187.
67.
EbertE. (2012). Gastrointestinal involvement in spinal cord injury: a clinical perspective. J. Gastrointestin. Liver Dis., 21, 75–82.
68.
AidinoffE., FrontL., ItzkovichM., BluvshteinV., GelernterI., HartJ., Biering-SorensenF., WeeksC., LarameeM.T., CravenC., HitzigS.L., GlaserE., ZeiligG., AitoS., ScivolettoG., MecciM., ChadwickR.J., El MasryW.S., OsmanA., GlassC.A., SoniB.M., GardnerB.P., SavicG., BergstromE.M., SilvaP., and CatzA. (2011). Expected spinal cord independence measure, third version, scores for various neurological levels after complete spinal cord lesions. Spinal Cord, 49, 893–896.
69.
OtaT., AkaboshiK., NagataM., SonodaS., DomenK., SekiM., and ChinoN. (1996). Functional assessment of patients with spinal cord injury: measured by the motor score and the Functional Independence Measure. Spinal Cord, 34, 531–535.
70.
FranzS., KirshblumS.C., WeidnerN., RuppR., SchuldC. and EMSCI StudyGroup. (2016). Motor levels in high cervical spinal cord injuries: Implications for the International Standards for Neurological Classification of Spinal Cord Injury. J. Spinal Cord Med., 39, 513–517.
71.
InoueS., TaniT., TaniguchiS., and YamamotoH. (2003). The motor-evoked potentials elicited from the deltoid muscle by transcranial magnetic stimulation with a standardized facilitation: the potential diagnostic utility for C5 radiculopathy. Spine (Phila Pa 1976) 28, 276–281.
72.
KramerJ.L., LammertseD.P., SchubertM., CurtA., and SteevesJ.D. (2012). Relationship between motor recovery and independence after sensorimotor-complete cervical spinal cord injury. Neurorehabil. Neural Repair, 26, 1064–1071.
73.
TsaiC.T., ChenH.W., and ChangC.W. (2003). Assessments of chronodispersion and tacheodispersion of F waves in patients with spinal cord injury. Am. J. Phys. Med. Rehabil., 82, 498–503.
74.
WeberF. (1998). The diagnostic sensitivity of different F wave parameters. J. Neurol. Neurosurg. Psychiatry, 65, 535–540.
75.
CurtA., KeckM.E. and DietzV. (1997). Clinical value of F-wave recordings in traumatic cervical spinal cord injury. Electroencephalogr. Clin. Neurophysiol., 105, 189–193.
76.
ThomasC.K., HagerC.K., and KleinC.S. (2017). Increases in human motoneuron excitability after cervical spinal cord injury depend on the level of injury. J. Neurophysiol., 117, 684–691.
77.
KesslerK.M., PinaI., GreenB., BurnettB., LaigholdM., BilskerM., PalomoA.R., and MyerburgR.J. (1986). Cardiovascular findings in quadriplegic and paraplegic patients and in normal subjects. Am. J. Cardiol., 58, 525–530.
78.
HarkemaS.J., WangS., AngeliC.A., ChenY., BoakyeM., UgiliwenezaB., and HirschG.A. (2018). Normalization of blood pressure with spinal cord epidural stimulation after severe spinal cord injury. Front Hum Neurosci, 12, 83.
79.
FornerJ.V. (1980). Lung volumes and mechanics of breathing in tetraplegics. Paraplegia, 18, 258–266.
80.
SteevesJ.D., KramerJ.K., FawcettJ.W., CraggJ., LammertseD.P., BlightA.R., MarinoR.J., DitunnoJ.F.Jr., ColemanW.P., GeislerF.H., GuestJ., JonesL., BurnsS., SchubertM., van HedelH.J., CurtA. and EMSCI StudyGroup. (2011). Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord, 49, 257–265.
81.
FranzS., SchuldC., WeidnerN., RuppR. S, chubertM. and EMSCI study Group. (2015). Neurological and functional recovery profiles of lesion specific level and severity within the 1st year after trauamtic and ischemic spinal cord injury. Presented at ASIA ISCoS, Montreal, Canada.
82.
JungD.I., HaJ., KangB.T., KimJ.W., QuanF.S., LeeJ.H., WooE.J., and ParkH.M. (2009). A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J. Neurol. Sci., 285, 67–77.
83.
TsaiM.C., WeiC.P., LeeD.Y., TsengY.T., TsaiM.D., ShihY.L., LeeY.H., ChangS.F., and LeuS.J. (2008). Inflammatory mediators of cerebrospinal fluid from patients with spinal cord injury. Surg. Neurol., 70, Suppl. 1, 19–24.
84.
HuberE., CurtA., and FreundP. (2015). Tracking trauma-induced structural and functional changes above the level of spinal cord injury. Curr. Opin. Neurol., 28, 365–372.
85.
SunX., JonesZ.B., ChenX.M., ZhouL., SoK.F., and RenY. (2016). Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J. Neuroinflammation, 13, 260.
86.
VaqueroJ., ZuritaM., RicoM.A., BonillaC., AguayoC., FernandezC., TapiadorN., SevillaM., MorejonC., MontillaJ., MartinezF., MarinE., BustamanteS., VazquezD., CarballidoJ., RodriguezA., MartinezP., GarciaC., OvejeroM., FernandezM.V., and Neurological Cell TherapyGroup (2017). Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury. Cytotherapy, 19, 349–359.
87.
SaitoF., NakataniT., IwaseM., MaedaY., HirakawaA., MuraoY., SuzukiY., OnoderaR., FukushimaM., and IdeC. (2008). Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J. Trauma, 64, 53–59.
88.
KumarA.A., KumarS.R., NarayananR., ArulK., and BaskaranM. (2009). Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp. Clin. Transplant., 7, 241–248.
89.
KroinJ.S., AliA., YorkM., and PennR.D. (1993). The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery, 33, 226–230.
90.
BernardsC.M. (2006). Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology, 105, 169–178.
91.
Dreha-KulaczewskiS., JosephA.A., MerboldtK.D., LudwigH.C., GartnerJ. and FrahmJ. (2015). Inspiration is the major regulator of human CSF flow. J. Neurosci., 35, 2485–2491.
92.
LankfordK.L., ArroyoE.J., NazimekK., BryniarskiK., AskenaseP.W., and KocsisJ.D. (2018). Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord. PLoS One, 13, e0190358.
93.
BuddensiekJ., DresselA., KowalskiM., RungeU., SchroederH., HermannA., KirschM., StorchA., and SabolekM. (2010). Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiation. BMC Neurosci. 11, 48.
94.
KivisakkP., MahadD.J., CallahanM.K., TrebstC., TuckyB., WeiT., WuL., BaekkevoldE.S., LassmannH., StaugaitisS.M., CampbellJ.J., and RansohoffR.M.(2003). Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100, 8389–8394.
95.
DominiciM., Le BlancK., MuellerI., Slaper-CortenbachI., MariniF., KrauseD., DeansR., KeatingA., ProckopD., and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315–317.
96.
DanesA., HayesK., TrorublyR., KramerJ., CloseT., and GuestJ. (2006). Cytokine concentrations in the cerebrospinal fluid of individuals with chronic spinal cord injury undergoing surgery for syringomyelia or detethering. Society for Neuroscience Conference Abstract 285.15. Atlanta, GA.
97.
KwonB.K., StammersA.M., BelangerL.M., BernardoA., ChanD., BishopC.M., SlobogeanG.P., ZhangH., UmedalyH., GiffinM., StreetJ., BoydM.C., PaquetteS.J., FisherC.G., and DvorakM.F. (2010). Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma, 27, 669–682.
98.
Morganti-KossmannM.C., HansV.H., LenzlingerP.M., DubsR., LudwigE., TrentzO., and KossmannT. (1999). TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood–brain barrier function. J. Neurotrauma, 16, 617–628.
99.
SiddallP.J., and LoeserJ.D. (2001). Pain following spinal cord injury. Spinal Cord, 39, 63–73.
100.
StormerS., GernerH.J., GruningerW., MetzmacherK., FollingerS., WienkeC., AldingerW., WalkerN., ZimmermannM., and PaeslackV. (1997). Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord, 35, 446–455.
101.
FinnerupN.B., JohannesenI.L., SindrupS.H., BachF.W., and JensenT.S. (2001). Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord, 39, 256–262.
102.
HanleyM.A., MasedoA., JensenM.P., CardenasD., and TurnerJ.A. (2006). Pain interference in persons with spinal cord injury: classification of mild, moderate, and severe pain. J. Pain, 7, 129–133.
103.
TanseyK.E. (2012). Profiling motor control in spinal cord injury: moving towards individualized therapy and evidence-based care progression. J. Spinal Cord Med., 35, 305–309.
104.
SherwoodA.M., DimitrijevicM.R., and McKayW.B. (1992). Evidence of subclinical brain influence in clinically complete spinal cord injury: discomplete SCI. J. Neurol. Sci., 110, 90–98.
105.
LiK., AtkinsonD., BoakyeM., TolfoC.Z., AslanS., GreenM., McKayB., OvechkinA., and HarkemaS.J. (2012). Quantitative and sensitive assessment of neurophysiological status after human spinal cord injury. J. Neurosurg. Spine, 17, 77–86.
106.
HarkemaS., GerasimenkoY., HodesJ., BurdickJ., AngeliC., ChenY., FerreiraC., WillhiteA., RejcE., GrossmanR.G., and EdgertonV.R. (2011). Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. Lancet, 377, 1938–1947.
107.
PetersonC.L., RogersL.M., MogkJ.P., BednarM.S., BrydenA.M., KeithM.W., PerreaultE.J., and MurrayW.M. (2014). Posture-dependent changes in corticomotor excitability of the biceps after spinal cord injury and tendon transfer. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2014, 4302–4305.
108.
SaadehP.B., CrisafulliC.F., SosnerJ., and WolfE. (1993). Needle electromyography of the diaphragm: a new technique. Muscle Nerve, 16, 15–20.
109.
SaywellS.A., AnissimovaN.P., FordT.W., MeehanC.F., and KirkwoodP.A. (2007). The respiratory drive to thoracic motoneurones in the cat and its relation to the connections from expiratory bulbospinal neurones. J. Physiol., 579, 765–782.
110.
GandeviaS.C., and KirkwoodP.A. (2011). Spinal breathing: stimulation and surprises. J. Physiol., 589, 2661–2662.
111.
BeisteinerR., HollingerI., RathJ., WurnigM., HilbertM., KlingerN., GeisslerA., FischmeisterF., WoberC., KloschG., MillesiH., GrisoldW., AuffE., and SchmidhammerR. (2011). New type of cortical neuroplasticity after nerve repair in brachial plexus lesions. Arch. Neurol., 68, 1467–1470.
112.
CarlstedtT., AnandP., HtutM., MisraP., and SvenssonM. (2004). Restoration of hand function and so called “breathing arm” after intraspinal repair of C5-T1 brachial plexus avulsion injury. Case report. Neurosurg. Focus, 16, E7.
113.
HtutM., MisraV.P., AnandP., BirchR., and CarlstedtT. (2007). Motor recovery and the breathing arm after brachial plexus surgical repairs, including re-implantation of avulsed spinal roots into the spinal cord. J. Hand Surg. Eur. Vol., 32, 170–178.
114.
FordT.W., AnissimovaN.P., MeehanC.F., and KirkwoodP.A. (2016). Functional plasticity in the respiratory drive to thoracic motoneurons in the segment above a chronic lateral spinal cord lesion. J. Neurophysiol., 115, 554–567.
115.
ZholudevaL.V., KarlinerJ.S., DoughertyK.J., and LaneM.A. (2017). Anatomical recruitment of spinal V2a interneurons into phrenic motor circuitry after high cervical spinal cord injury. J Neurotrauma, 34, 3058–3065.
116.
BraegelmannK.M., StreeterK.A., FieldsD.P., and BakerT.L. (2017). Plasticity in respiratory motor neurons in response to reduced synaptic inputs: a form of homeostatic plasticity in respiratory control?. Exp. Neurol., 287, 225–234.
117.
BezdudnayaT., MarchenkoV., ZholudevaL.V., SpruanceV.M., and LaneM.A. (2017). Supraspinal respiratory plasticity following acute cervical spinal cord injury. Exp. Neurol., 293, 181–189.
118.
SperryM.A., and GoshgarianH.G. (1993). Ultrastructural changes in the rat phrenic nucleus developing within 2 h after cervical spinal cord hemisection. Exp. Neurol., 120, 233–244.
119.
GoshgarianH.G., YuX.J., and RafolsJ.A. (1989). Neuronal and glial changes in the rat phrenic nucleus occurring within hours after spinal cord injury. J. Comp. Neurol., 284, 519–533.
120.
BordoniB., and ZanierE. (2013). Anatomic connections of the diaphragm: influence of respiration on the body system. J. Multidiscip. Healthc., 6, 281–291.
121.
VasquezN., GallA., EllawayP.H., and CraggsM.D. (2013). Light touch and pin prick disparity in the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI). Spinal Cord, 51, 375–378.
122.
HalesM., BirosE., and ReznikJ.E. (2015). Reliability and validity of the sensory component of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI): a systematic review. Top. Spinal Cord Inj. Rehabil., 21, 241–249.
123.
BhanotY., RaoS., GhoshD., BalarajuS., RadhikaC.R., and Satish KumarK.V. (2011). Autologous mesenchymal stem cells in chronic spinal cord injury. Br. J. Neurosurg., 25, 516–522.
124.
KirshblumS.C., BurnsS.P., Biering-SorensenF., DonovanW., GravesD.E., JhaA., JohansenM., JonesL., KrassioukovA., MulcaheyM.J., Schmidt-ReadM., and WaringW. (2011). International standards for neurological classification of spinal cord injury (revised 2011). J. Spinal Cord Med., 34, 535–546.
125.
DukesE.M., KirshblumS., AimettiA.A., QinS.S., BornheimerR.K., and OsterG. (2017). Relationship of American Spinal Injury Association Impairment Scale grade to post-injury hospitalization and costs in thoracic spinal cord injury. Neurosurgery. [Epub ahead of print; DOI:10.1093/neuros/nyx425.]
126.
KirshblumS.C., BotticelloA.L., Dyson-HudsonT.A., ByrneR., MarinoR.J., and LammertseD.P. (2016). Patterns of sacral sparing components on neurologic recovery in newly injured persons with traumatic spinal cord injury. Arch. Phys. Med. Rehabil., 97, 1647–1655.
127.
Seto-PoonM., MadronioM., KirknessJ.P., AmisT.C., BythK.. and LimC.L. (2005). Decrement of the skin conductance response to repeated volitional inspiration. Clin. Neurophysiol., 116, 1172–1180.
128.
HubliM., and KrassioukovA.V. (2015). How reliable are sympathetic skin responses in subjects with spinal cord injury?. Clin. Auton. Res., 25, 117–124.
129.
CurtA., WeinhardtC., and DietzV. (1996). Significance of sympathetic skin response in the assessment of autonomic failure in patients with spinal cord injury. J. Auton. Nerv. Syst., 61, 175–180.
130.
HincapieJ.G., and KirschR.F. (2009). Feasibility of EMG-based neural network controller for an upper extremity neuroprosthesis. IEEE Trans. Neural Syst. Rehabil. Eng., 17, 80–90.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
